Thus, the simultaneous activation of NFκB and JAK/STAT signaling in TRIM28-deficient cells provides a plausible mechanistic link to enhanced expression of CD24/CD47, suggesting that TRIM28 modulates tumor–immune interactions through coordinated regulation of cytokine and adhesion pathways. The gene discussed is TRIM28; the disease is neoplasm.